Non-HDL best predictor cardiovascular risk

In this webcast, prof. Frank Visseren (UMC Utrecht) discusses a meta-analysis in which several predictors of cardiovascular risk during statin therapy have been compared. The article was published on March 29 in the Clinician's corner of the Journal of the American Medical Association (JAMA). In clinical practice, the best predictor seems to be non-HDL - that is, cholesterol minus HDL.